摘要 |
The present invention relates to an agent for reducing ischaemic damage to an organ, in particular to a heart and a brain, pharmaceutical compositions comprising said agent and the use of said agent for the treatment of ischaemic diseases to the heart and the brain. The agent comprises a substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivative according to Formula (I) the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof, the N-oxide forms thereof and the prodrugs thereof. In particular are claimed the compounds according to Formula (I) in which A=B is C-O or SO<SUB>2</SUB>, X is a covalent bond, R<SUP>1 </SUP>is alkyloxy, alkyloxyalkyl, Ar or NR<SUP>9</SUP>R<SUP>10</SUP>, wherein R<SUP>9 </SUP>and R<SUP>10 </SUP>each independently are hydrogen or Ar; or A=B and R<SUP>1 </SUP>together form a benzoxazolyl radical; p is zero, R<SUP>3 </SUP>is benzyl optionally substituted with hydroxy, alkyl or alkyloxycarbonyl and R<SUP>4 </SUP>and R<SUP>5 </SUP>each are hydrogen. The use of said agents has important clinical ramifications with regard to the reduction of ischaemic damage to an organ in a mammal, in particular to a heart and/or a brain, the prevention of coronary artery diseases in a mammal by inducing a cardioprotective effect and the treatment and prevention of stroke. |